Novavax Surges Following Strong Q1 Revenue Boost

Novavax shares are trading higher after the company reported a significant increase in Q1 2025 revenues driven by Nuvaxovid sales and lucrative partnerships, projecting total revenue of $975 million to $1,025 million for the year.